Topics

High-grade gliomas | Treatment | Clinical trials

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials

OVERALL MANAGEMENT

□ BRAIN EDEMA MNGT

□ DRUG DELIVERY

□ DRUG SENSITIVITY TESTING

□ NEOADJUVANT THERAPIES

CHEMOTHERAPY

□ BXQ-350

□ BERUBICIN

□ CISPLATIN

□ EVEROLIMUS

□ IRINOTECAN

□ TAXANES

□ TEMOZOLOMIDE

□ TOPOTECAN

IMMUNOTHERAPY

□ CAR-T-Cells

□ INTERLEUKINS

□ VACCINES

□ VIRUSES

INTEGRATIVE MEDICINE

□ MEDITATION

OFF-LABEL MEDICATIONS

□ ACETAZOLAMIDE

□ MEBENDAZOLE

□ SITAGLIPTIN

RADIOTHERAPY

□ BRACHYTHERAPY

□ MARGINS

□ RE-IRRADIATION

SIDE-EFFECTS

□ THROMBOEMBOLISM

SUPPORTIVE CARE

□ PSYCHOSOCIAL DISTRESS

TARGETED THERAPY

□ APATINIB

□ AUCELICICLIB

□ BEVACIZUMAB

□ CAMRELIZUMAB

□ HYPOXIA-TARG RADIOLIG THER

□ IPILIMUMAB

□ LENVATINIB

□ NILOTINIB

□ NIVOLUMAB

□ SM-1

□ SYHA1813

□ TARG RADIONUCLIDE THER

□ TERAMEPROCOL

□ TG02

ULTRASOUND THERAPY

□ FOCUSED ULTRASOUND

□ SONODYNAMIC THERAPY